HIV-1 RNA Combo 1

HIV Combo Test Overview

The HIV combo test, also known as the HIV Ag/Ab combo test, is a sophisticated diagnostic tool designed to detect both the antibodies and the p24 antigen of the Human Immunodeficiency Virus (HIV). This test plays a crucial role in the early detection and diagnosis of HIV-1 and HIV-2 infections, as it can identify the presence of the virus even before the body has developed antibodies.

By employing advanced techniques such as chemiluminescent microparticle immunoassay (CMIA) or enzyme-linked immunosorbent assay (ELISA), the HIV Combo Test accurately detects the presence of HIV p24 antigen and antibodies to HIV-1 and HIV-2 in human serum, plasma, or whole blood.

The HIV combo test serves as a vital tool for healthcare professionals in their efforts to prevent the transmission of HIV through blood, blood components, cells, tissues, and organs. Its ability to detect the virus in the early stages of infection makes it an invaluable asset in the fight against the spread of HIV.

HIV-1 RNA, a vital component of the human immunodeficiency virus type 1, is its genetic material. The HIV-1 RNA Combo 1 diagnostic test employs a comprehensive approach, integrating both Flow Cytometry and Real-Time Polymerase Chain Reaction (RT-PCR) techniques to detect and quantify human immunodeficiency virus type 1 (HIV-1) RNA in a patient's blood sample. This combination of methodologies enhances the accuracy and reliability of HIV diagnosis and monitoring. Flow Cytometry allows for the enumeration of CD4+ T lymphocytes, a key component of the immune system targeted by HIV, providing valuable information about the immune status of the individual. Concurrently, Real-Time PCR amplifies and quantifies HIV-1 RNA, offering a sensitive and specific measure of viral load. By combining these two diagnostic approaches, healthcare professionals can gain comprehensive insights into the progression of HIV infection, tailor treatment strategies, and monitor the effectiveness of antiretroviral therapy. The HIV-1 RNA Combo 1 test serves as a powerful tool in the ongoing management and care of individuals living with HIV, facilitating timely interventions to optimize health outcomes.